Australia markets closed

Vectus Biosystems Limited (VBS.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.32000.0000 (0.00%)
At close: 10:08AM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 17.02M
Enterprise value 14.14M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.83
Enterprise value/revenue 78.55k
Enterprise value/EBITDA -4.42

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 3-64.64%
S&P500 52-week change 315.38%
52-week high 30.9050
52-week low 30.3000
50-day moving average 30.3345
200-day moving average 30.4361

Share statistics

Avg vol (3-month) 33.12k
Avg vol (10-day) 34.87k
Shares outstanding 553.19M
Implied shares outstanding 653.21M
Float 823.27M
% held by insiders 148.13%
% held by institutions 18.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin -254.62%
Operating margin (ttm)-168.35%

Management effectiveness

Return on assets (ttm)-47.33%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.35M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-40.40%
Gross profit (ttm)1.35M
EBITDA -3.2M
Net income avi to common (ttm)-3.45M
Diluted EPS (ttm)-0.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.95M
Total cash per share (mrq)0.05
Total debt (mrq)70.21k
Total debt/equity (mrq)1.99%
Current ratio (mrq)4.14
Book value per share (mrq)0.07

Cash flow statement

Operating cash flow (ttm)-2.35M
Levered free cash flow (ttm)-1.6M